
Allergan, Inc. announced that the FDA has approved a fully in vitro, cell-based assay for use in the stability and potency testing of onabotulinumtoxinA (Botox and Botox Cosmetic, Allergan). The newly-approved assay will be implemented immediately for release of product for sale in the U.S.


.png)


